EVOTEC SE (1EVT.MI) Fundamental Analysis & Valuation

BIT:1EVT • DE0005664809

Current stock price

4.226 EUR
-1.03 (-19.63%)
Last:

This 1EVT.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. 1EVT.MI Profitability Analysis

1.1 Basic Checks

  • 1EVT had negative earnings in the past year.
  • In the past year 1EVT had a positive cash flow from operations.
  • In multiple years 1EVT reported negative net income over the last 5 years.
  • Each year in the past 5 years 1EVT had a positive operating cash flow.
1EVT.MI Yearly Net Income VS EBIT VS OCF VS FCF1EVT.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

  • 1EVT's Return On Assets of -8.97% is on the low side compared to the rest of the industry. 1EVT is outperformed by 77.78% of its industry peers.
  • 1EVT has a Return On Equity of -19.87%. This is in the lower half of the industry: 1EVT underperforms 72.22% of its industry peers.
Industry RankSector Rank
ROA -8.97%
ROE -19.87%
ROIC N/A
ROA(3y)-7.25%
ROA(5y)-2.34%
ROE(3y)-14.29%
ROE(5y)-5.27%
ROIC(3y)N/A
ROIC(5y)N/A
1EVT.MI Yearly ROA, ROE, ROIC1EVT.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

  • 1EVT's Gross Margin of 10.82% is on the low side compared to the rest of the industry. 1EVT is outperformed by 83.33% of its industry peers.
  • In the last couple of years the Gross Margin of 1EVT has declined.
  • 1EVT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.23%
GM growth 5Y-13.5%
1EVT.MI Yearly Profit, Operating, Gross Margins1EVT.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

5

2. 1EVT.MI Health Analysis

2.1 Basic Checks

  • 1EVT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, 1EVT has more shares outstanding
  • The number of shares outstanding for 1EVT has been increased compared to 5 years ago.
  • Compared to 1 year ago, 1EVT has an improved debt to assets ratio.
1EVT.MI Yearly Shares Outstanding1EVT.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
1EVT.MI Yearly Total Debt VS Total Assets1EVT.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

  • 1EVT has an Altman-Z score of 0.83. This is a bad value and indicates that 1EVT is not financially healthy and even has some risk of bankruptcy.
  • 1EVT's Altman-Z score of 0.83 is on the low side compared to the rest of the industry. 1EVT is outperformed by 83.33% of its industry peers.
  • A Debt/Equity ratio of 0.48 indicates that 1EVT is not too dependend on debt financing.
  • 1EVT has a better Debt to Equity ratio (0.48) than 77.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Altman-Z 0.83
ROIC/WACCN/A
WACC8.01%
1EVT.MI Yearly LT Debt VS Equity VS FCF1EVT.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

  • A Current Ratio of 2.12 indicates that 1EVT has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.12, 1EVT belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
  • A Quick Ratio of 2.03 indicates that 1EVT has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 2.03, 1EVT belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.12
Quick Ratio 2.03
1EVT.MI Yearly Current Assets VS Current Liabilites1EVT.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

3

3. 1EVT.MI Growth Analysis

3.1 Past

  • The earnings per share for 1EVT have decreased strongly by -136.17% in the last year.
  • 1EVT shows a decrease in Revenue. In the last year, the revenue decreased by -2.67%.
  • Measured over the past years, 1EVT shows a quite strong growth in Revenue. The Revenue has been growing by 12.29% on average per year.
EPS 1Y (TTM)-136.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-8.5%
Revenue 1Y (TTM)-2.67%
Revenue growth 3Y8.85%
Revenue growth 5Y12.29%
Sales Q2Q%-11.36%

3.2 Future

  • The Earnings Per Share is expected to grow by 19.75% on average over the next years. This is quite good.
  • Based on estimates for the next years, 1EVT will show a small growth in Revenue. The Revenue will grow by 6.85% on average per year.
EPS Next Y59.73%
EPS Next 2Y35.6%
EPS Next 3Y28%
EPS Next 5Y19.75%
Revenue Next Year-2.27%
Revenue Next 2Y4.05%
Revenue Next 3Y6.5%
Revenue Next 5Y6.85%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
1EVT.MI Yearly Revenue VS Estimates1EVT.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
1EVT.MI Yearly EPS VS Estimates1EVT.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.5 -0.5 1 -1

1

4. 1EVT.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • 1EVT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year 1EVT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
1EVT.MI Price Earnings VS Forward Price Earnings1EVT.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, 1EVT is valued a bit more expensive than the industry average as 77.78% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 905.71
1EVT.MI Per share data1EVT.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

  • 1EVT's earnings are expected to grow with 28.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.6%
EPS Next 3Y28%

0

5. 1EVT.MI Dividend Analysis

5.1 Amount

  • 1EVT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

1EVT.MI Fundamentals: All Metrics, Ratios and Statistics

EVOTEC SE

BIT:1EVT (3/16/2026, 7:00:00 PM)

4.226

-1.03 (-19.63%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-05
Earnings (Next)N/A
Inst Owners60.42%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.50B
Revenue(TTM)756.33M
Net Income(TTM)-158.98M
Analysts78.46
Price Target9.56 (126.22%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-6.97%
Min Revenue beat(2)-9.17%
Max Revenue beat(2)-4.77%
Revenue beat(4)0
Avg Revenue beat(4)-4.99%
Min Revenue beat(4)-9.17%
Max Revenue beat(4)-0.93%
Revenue beat(8)1
Avg Revenue beat(8)-3.74%
Revenue beat(12)4
Avg Revenue beat(12)1.1%
Revenue beat(16)7
Avg Revenue beat(16)2.93%
PT rev (1m)1.15%
PT rev (3m)-1.81%
EPS NQ rev (1m)366.67%
EPS NQ rev (3m)300%
EPS NY rev (1m)5.49%
EPS NY rev (3m)-54.9%
Revenue NQ rev (1m)7.16%
Revenue NQ rev (3m)-6.47%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.79%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.98
P/FCF N/A
P/OCF 1064.31
P/B 1.88
P/tB 3
EV/EBITDA 905.71
EPS(TTM)-1.11
EYN/A
EPS(NY)-0.18
Fwd EYN/A
FCF(TTM)-0.26
FCFYN/A
OCF(TTM)0
OCFY0.09%
SpS2.13
BVpS2.25
TBVpS1.41
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -8.97%
ROE -19.87%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 10.82%
FCFM N/A
ROA(3y)-7.25%
ROA(5y)-2.34%
ROE(3y)-14.29%
ROE(5y)-5.27%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.23%
GM growth 5Y-13.5%
F-Score4
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Debt/EBITDA 209.82
Cap/Depr 90.72%
Cap/Sales 12.19%
Interest Coverage N/A
Cash Conversion 76.3%
Profit Quality N/A
Current Ratio 2.12
Quick Ratio 2.03
Altman-Z 0.83
F-Score4
WACC8.01%
ROIC/WACCN/A
Cap/Depr(3y)186.39%
Cap/Depr(5y)182.37%
Cap/Sales(3y)22.79%
Cap/Sales(5y)21.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-136.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-8.5%
EPS Next Y59.73%
EPS Next 2Y35.6%
EPS Next 3Y28%
EPS Next 5Y19.75%
Revenue 1Y (TTM)-2.67%
Revenue growth 3Y8.85%
Revenue growth 5Y12.29%
Sales Q2Q%-11.36%
Revenue Next Year-2.27%
Revenue Next 2Y4.05%
Revenue Next 3Y6.5%
Revenue Next 5Y6.85%
EBIT growth 1Y-6.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year132.47%
EBIT Next 3Y50.57%
EBIT Next 5Y33.86%
FCF growth 1Y52.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y107.69%
OCF growth 3Y-46.98%
OCF growth 5Y-15.47%

EVOTEC SE / 1EVT.MI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for EVOTEC SE?

ChartMill assigns a fundamental rating of 3 / 10 to 1EVT.MI.


What is the valuation status for 1EVT stock?

ChartMill assigns a valuation rating of 1 / 10 to EVOTEC SE (1EVT.MI). This can be considered as Overvalued.


What is the profitability of 1EVT stock?

EVOTEC SE (1EVT.MI) has a profitability rating of 1 / 10.


Can you provide the financial health for 1EVT stock?

The financial health rating of EVOTEC SE (1EVT.MI) is 5 / 10.